Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE Cervical ultrasonography has no additional value over negative <sup>18</sup>F-FDG PET/CT scans for diagnosing cervical lymph node metastases in patients with oesophageal cancer. 29218619 2018
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE Overall, 18F-FDG PET/CT have a moderate to low sensitivity and a high to moderate specificity for detection of regional nodal metastasis in esophageal cancer. 30622778 2018
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE This study aimed to evaluate the diagnostic performance of <sup>18</sup>F-FDG PET/CT for the detection of interval metastasis and to identify predictors of interval metastases in a large cohort of oesophageal cancer patients. 29663014 2018
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE The analysis included diagnostic studies describing the accuracy of cervical ultrasonography and integrated F-FDG PET/CT or standalone F-FDG PET and CT for detecting cervical lymph node metastases in patients with esophageal cancer. 29672463 2018
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE This study is the first to clarify the FDG-PET performance for EC screening. 28487611 2017
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE A comparative study of target volumes based on <sup>18</sup>F-FDG PET-CT and ten phases of 4DCT for primary thoracic squamous esophageal cancer. 28123302 2017
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE Relative change in FDG uptake after 14 days of CRT is not associated with DFS in patients with esophageal cancer undergoing neoadjuvant chemoradiotherapy followed by surgery. 27001344 2017
CUI: C0546837
Disease: Malignant neoplasm of esophagus
Malignant neoplasm of esophagus
0.100 Biomarker disease BEFREE Texture analysis of <sup>18</sup>F-FDG PET/CT to predict tumour response and prognosis of patients with esophageal cancer treated by chemoradiotherapy. 27613542 2017